After the UK’s medical regulator approved the coronavirus vaccine co-developed by Pfizer and BioNtech on Wednesday, the rest of the world is trying hard to get the inoculation trials in place as early as January 2021.
Australia’s pharmaceutical regulator, Therapeutic Goods Administration (TGA), said Thursday it will review Pfizer’s COVID-19 vaccine by January 2021, on course with the first vaccination in March 2021.
On Wednesday, the Premier of the Canadian province of Alberta said that the country expects covid vaccine arrival from January 4, 2021, conveying information from the country's Federal government.
The concerns over the coronavirus growth have resurfaced, offsetting the vaccine optimism in Asia.
The S&P 500 futures trade modestly flat near the 3,670 region.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.